Based on publicly disclosed timelines, January 2012:

To learn more about these drug programs, please see the following links:
Trophos
Repligen
Isis/Biogen
California Stem Cells
NINDS SMA Project
The Ohio State University
Genethon
Genzyme/Sanofi
Roche/PTC/SMA Foundation
Novartis
Paratek